Renal endothelin system in diabetes: Comparison of angiotensin-converting enzyme inhibition and endothelin-A antagonism

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Hocher, Berthold ^a   Lun, Andreas ^a   Priem, Friedrich ^a   Neumayer, Hans H ^a   Raschack, Manfred ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Knoll AG   (Germany)

Author keywords

Diabetes; ET system; Kidney

Indexed keywords

DARUSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR; PHENYLPROPIONIC ACID DERIVATIVE; PYRIMIDINE DERIVATIVE;

ALBUMINURIA; ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; KIDNEY FUNCTION TEST; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEINURIA; RAT; URINE; WISTAR RAT;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; ENDOTHELINS; KIDNEY; KIDNEY FUNCTION TESTS; MICE; PHENYLPROPIONATES; PROTEINURIA; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN;

EID: 0031630241     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00141     Document Type: Review

References (10)

1. Schleicher F, Kolm V, Ceol M, Nerlich A. Structural and functional changes in diabetic glomerulopathy. Kidney Blood Press Res 1996;19:305-15.
2. Hocher B, Thöne-Reineke C, Bauer C, Raschack M, Neumayer HH. The paracrine endothelin system; pathophysiology and implications in clinical medicine. Eur J Clin Chem Clin Biochem 1997; 35:175-89.
3. Yamauchi T, Ohnaka K, Takayananagi R, Umeda F, Nawata H. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett 1990;267: 16-8.
4. Hocher B, Thöne-Reineke C, Rohmeiss P, et al. Endothelin-1 transgenic mice develop renal cysts, interstitial fibrosis and glomerulosclerosis but not hypertension. J Clin Invest 1997;99: 1380-9.
5. Hocher B, Liefeldt L, Thöne-Reineke C, et al. Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene. Hypertension 1996;28:196-201.
6. Watanabe N, Kamei A, Ohkubo M, et al. Urinary protein as measured with a pyrogallol red-molybdate complex manually and in a Hitachi 726 automated analyzer. Clin Chem 1986;32:1551-4.
7. Hofmann W, Guder WG. A diagnostic programme for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 1989;27:589-600.
8. Fuku M, Nakamura T, Ebihara I, et al. Gene expression for endothelin and their receptors in glomeruli of diabetic rats. J Lab Clin Med 1993;122:149-56.
9. Mattyus I, Zimmerhackl LB, Schwarz A, Brandis M, Miltlenyi M, Tulasay T. Elevated urinary excretion of endothelin in insulin-dependent diabetes mellitus of physical exercises. Acta Paediatr 1996;85:1058-61.
10. Hocher B, Rohmeiss P, Zart R, et al. Distribution of endothelin receptor subtypes in the rat kidney: renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan. Eur J Clin Chem Clin Biochem 1995;33:463-72.